Last reviewed · How we verify

PregLem SA — Portfolio Competitive Intelligence Brief

PregLem SA pipeline: 0 marketed, 0 filed, 7 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 7 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
PGL4001, progestin, drug free period PGL4001, progestin, drug free period phase 3 Progestin / Selective Progesterone Receptor Modulator Progesterone receptor Contraception / Women's Health
PGL4001 PGL4001 phase 3 Selective progesterone receptor modulator (SPRM) Progesterone receptor (PR) Gynecology / Women's Health
PGL4001, placebo, drug free period PGL4001, placebo, drug free period phase 3 Progesterone receptor agonist Progesterone receptor (PR) Obstetrics / Women's Health
Ulipristal Acetate - open label Ulipristal Acetate - open label phase 3 Selective progesterone receptor modulator Progesterone receptor Reproductive health
PGL4001, progestin PGL4001, progestin phase 3 Progestin (progesterone receptor agonist) Progesterone receptor (PR) Gynecology / Women's Health
PGL4001 matching placebo and iron PGL4001 matching placebo and iron phase 3 Progesterone receptor agonist Progesterone receptor (PR) Obstetrics/Gynecology
PGL4001 (ulipristal) and iron PGL4001 (ulipristal) and iron phase 3 Selective progesterone receptor modulator with iron supplementation Progesterone receptor (PR); iron supplementation (non-receptor target) Gynecology / Women's Health

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Allergan · 1 shared drug class
  2. Bayer · 1 shared drug class
  3. ObsEva SA · 1 shared drug class
  4. Organon and Co · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for PregLem SA:

Cite this brief

Drug Landscape (2026). PregLem SA — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/preglem-sa. Accessed 2026-05-14.

Related